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Abstract. Swine hepatitis E virus (HEV) appears to be common among pigs around the world. 
HEV is also considered a zoonotic disease and pigs are more likely the primary reservoir. Hepatitis 
caused by HEV infection has been a public health problem in developing countries. However, recent 
seroprevalence studies indicate that the HEV have been reported in several industrialized countries our 
researches aimed to investigate the prevalence of HEV antibodies in pigs from different breading 
conditions in the eastern region of Romania. A total of 340 serum samples collected during 2008-
2011, from clinically healthy pigs were tested using two commercial indirect ELISA. The overall 
prevalence of anti-HEV antibodies was 15.58%, the percentage of seropositive pigs varied greatly 
from herd to herd (0 – 44.4%). In addition, from the same region, serum samples of 112 humans were 
screened for the presence of anti-HEV IgG antibodies by ELISA (produced by MP Biomedicals). The 
sera from 8 humans (7.14%) were anti-HEV IgG reactive. This is the first study showing that HEV is 
prevalent in the Romanian pig herds. These results indicate that subclinical HEV infections may 
prevail in swine and human populations from the same region. 
 
Keywords: HEV, swine, human, ELISA 
 
Introduction. Hepatitis E virus (HEV), the sole member of the genus Hepevirus in the 
family Hepeviridae (Emerson et al., 2004), is the major cause of enterically transmitted non-
A, non-B hepatitis in humans. Hepatitis E is an acute self-limiting disease that is common in 
Asia and Africa and considered emerging in many industrialized countries. Since the first 
swine HEV strain was isolated in 1997 by Meng, it has been documented by more and more 
studies that swine is the largest viral reservoir of HEV and that hepatitis E is a zoonosis. HEV 
is a recently discovered virus and the relatively large and diverse species prone to infection 
with HEV suggest that the virus may readily adapt to new hosts. 
Materials and methods. Three hundred forty serum samples from swine in eastern 
Romania were collected in this study. Of these, 250 samples were tested for detection of IgG 
anti-HEV using a MP Biomedicals HEV ELISA kit (for humans) adapted for swine. Serum 
samples obtained from 90 pigs were tested using PrioCHECK® HEV Ab porcine (produced 
by Prionics). One hundred and twelve serums of humans were obtained from people in the 
check-up department of local hospitals from the eastern Romania. For the detection of anti-
HEV IgG was used the HEV ELISA kit produced by MP Biomedicals, according to the 
manufacturer’s recommendations. All specimens surveyed in this study were collected from 
2008 to 2011 and frozen at –20 °C and stored until analyzed. 
Results and discussions. The prevalence rates of anti-HEV antibodies in 250 swine 
sera were examined with a swine adapted ELISAs for anti-HEV IgG. The highest prevalence 
of anti-HEV IgG was observed in Brăila County, showing a 36.66% seroprevalence. 
In addition, using a specific commercial ELISA, the presence of anti-HEV antibodies 
was surveyed in five farms and three of them showed a prevalence of HEV antibodies, 
ranging from 12.5% to 44.4%. The overall prevalence of anti-HEV antibodies in Romanian 
pigs was 15.58%. All serological studies published so far in the literature conclude that 
hepatitis E is widespread in swine farms around the world. A retrospective study in U.S. 
shows that most pigs are infected at the age of 2-4 months (Meng XJ et al., 1997),with an  
increasing seroprevalence in pigs aged over four months. Regarding seroprevalence in sows, 
it is even higher, ranging from 60-73% (Seminal C. et al., 2008). Eighty-seven serum samples 
were collected from persons admitted to hospital with signs of clinical hepatitis.  
After serological examination were identified five positive sera for anti-HEV IgG. Out 
of 25 patients who had confirmed type B or C hepatitis, three were identified as positives for 
anti HEV IgG. The majority of autochthon cases of hepatitis E have been reported in people of 
middle-aged and elderly (RH Purcell, SU Emerson., 2008). Many factors such as hepatitis E 
virus strain (genotype or subtype), route of entry or other co-infections seem to play an 
important role in pathogenesis (C. Renou, 2008). Detection of anti-HEV antibodies in 3 people 
diagnosed with hepatitis B or C under serological surveillance demonstrates the possibility of 
overlapping infection in humans with different types of viruses that infect the liver. 
Conclusions.  
One important thing about this disease is to assess risk factors associated with hepatitis 
E infection and clinical consequences related to contact with the virus. A quantitative risk 
assessment must be made by identifying the transmission pathways. This approach can 
contribute to define surveillance strategies of hepatitis E infection. Impact of animal reservoir 
of human hepatitis E must be closely studied to assess whether and how to control zoonotic 
transmission. 
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